Company Filing History:
3 out of 3,539 
2 out of 2 
1 out of 1 Years Active: 2022-2024
Title: Jörg Hendle: Innovator in Anti-Coronavirus Antibodies
Introduction
Jörg Hendle is a notable inventor based in San Diego, CA, who has made significant contributions to the field of biotechnology. He holds three patents, focusing primarily on anti-coronavirus antibodies and their applications in treating and preventing conditions associated with SARS and COVID-19.
Latest Patents
Hendle's latest patents include innovative antibodies that bind to the spike proteins of SARS-CoV and SARS-CoV-2. These antibodies are designed for use in treating or preventing conditions related to these viruses, as well as for detecting their presence. His work is crucial in the ongoing fight against coronavirus-related diseases.
Career Highlights
Throughout his career, Jörg Hendle has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Abcellera Biologics Inc. His experience in these institutions has allowed him to contribute to groundbreaking research and development in the field of immunology.
Collaborations
Hendle has collaborated with talented individuals such as Kathryn Westendorf and Stefanie Zentelis. These partnerships have enhanced his research efforts and have been instrumental in advancing his innovative projects.
Conclusion
Jörg Hendle's work in developing anti-coronavirus antibodies showcases his commitment to addressing global health challenges. His patents and collaborations reflect his significant impact on the field of biotechnology and public health.